10-04-2026 02:00 via cell.com

Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy

Oral Spirulina hydrogel targets the gut–joint axis via barrier repair, microbiota remodeling, and immune balance, synergizing with standard rheumatoid arthritis therapies for enhanced efficacy.
Read more »

Biotechnology news



After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research
Chemical actuation expands the design space of living light materials
Mary-Dell Chilton Dies at 87; Helped Create First Genetically Modified Plant
Programmable mycolysins expand the antimicrobial toolkit against mycobacteria
The New Race to Find Treatments for Measles
With Measles Roaring Back, the Search for a Drug is On
Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here
As Ebola Spreads in East Africa, Will China Step Up?
J. Craig Venter (1946—2026)
China’s Rise in Drug Development Looms Over U.S.
Reprogramming halophilic life for low-salt biomanufacturing
Biotechnologies based on the fungal bioluminescence pathway
Blue at the edge
Desktop versie